Li's Large Pharmaceutical Factory (00950.HK) plans to invest 25 million yuan to participate in the Life and Health Industry Fund, and layout the biotechnology track.

Lee's Great Pharmaceutical Factory (00950.HK) announced that on May 11, 2026, the company's indirectly wholly-owned subsidiary, Zhaoke Hefei, general partner Ruifubo Jian, and other limited partners entered into a limited partnership agreement. Under this agreement, these partners contributed RMB 200 million to the fund, while Zhaoke Hefei agreed to contribute RMB 25 million to the fund, equivalent to approximately 12.5% of the fund's equity.